Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Cancer Cell
|
November 9, 2010
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer
Ferdinandos Skoulidis, Liam D Cassidy, Venkat Pisupati, et al.
Gastro Hep Advances
|
April 20, 2026
Electroporation-Induced Gastric Cancer Models Through Epithelial-Specific Genetic Modifications
Junya Arai, Masahiro Hata, Yosuke Ochiai, et al.
Gut
|
May 13, 2020
Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression
Ryota Takahashi, Marina Macchini, Masaki Sunagawa, et al.
Gut
|
January 20, 2019
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Carlo Maurer, Sam R Holmstrom, Jing He, et al.
Theranostics
|
April 16, 2020
Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>
Alireza Nabavizadeh, Thomas Payen, Alina C Iuga, et al.
Carcinogenesis
|
May 6, 2015
Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism
Filip Bednar, Heather K Schofield, Meredith A Collins, et al.
Nature Biomedical Engineering
|
March 29, 2022
High-speed light-sheet microscopy for the in-situ acquisition of volumetric histological images of living tissue
Kripa B Patel, Wenxuan Liang, Malte J Casper, et al.
Nature Communications
|
November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Nature Communications
|
October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2015
Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma
Salvia Jain, Xavier Jirau-Serrano, Kelly M Zullo, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Cancer Cell
|
November 9, 2010
Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer
Ferdinandos Skoulidis, Liam D Cassidy, Venkat Pisupati, et al.
Gastro Hep Advances
|
April 20, 2026
Electroporation-Induced Gastric Cancer Models Through Epithelial-Specific Genetic Modifications
Junya Arai, Masahiro Hata, Yosuke Ochiai, et al.
Gut
|
May 13, 2020
Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression
Ryota Takahashi, Marina Macchini, Masaki Sunagawa, et al.
Gut
|
January 20, 2019
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Carlo Maurer, Sam R Holmstrom, Jing He, et al.
Theranostics
|
April 16, 2020
Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>
Alireza Nabavizadeh, Thomas Payen, Alina C Iuga, et al.
Carcinogenesis
|
May 6, 2015
Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism
Filip Bednar, Heather K Schofield, Meredith A Collins, et al.
Nature Biomedical Engineering
|
March 29, 2022
High-speed light-sheet microscopy for the in-situ acquisition of volumetric histological images of living tissue
Kripa B Patel, Wenxuan Liang, Malte J Casper, et al.
Nature Communications
|
November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Nature Communications
|
October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Katherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2015
Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma
Salvia Jain, Xavier Jirau-Serrano, Kelly M Zullo, et al.
Page
of 13